🔎 Trials Near Me

Utama › Penyakit Crohn › California

Kajian klinikal Penyakit Crohn di California

37 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Clinnova Research ( Site 5110), Anaheim
  • Southern California Research Center ( Site 5044), Coronado
  • Om Research LLC ( Site 5038), Lancaster
  • dan 5 lagi
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Clinnova Research /ID# 280509, Anaheim
  • Southern California Res. Ctr /ID# 280476, Coronado
  • Gastro Care Institute /ID# 281071, Lancaster
  • dan 2 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastroenterology and Liver Institute, Escondido
  • United Clinical Research Institute, Murrieta
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Cedars Sinai Medical Center, Los Angeles
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05923073

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Southern California Res. Ctr /ID# 265549, Coronado
  • UC San Diego Health System /ID# 265565, La Jolla
  • uc davis medical center - patient support services building /ID# 265554, Sacramento
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Clinnova Research, Anaheim
  • Gastro Care Institute, Lancaster
  • United Gastroenterologists, Los Alamitos
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Clinnova Research, Anaheim
  • Southern California Research Center, Coronado
  • Om Research, LLC 1, Lancaster
  • dan 6 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • United Medical Doctors, Murrieta
  • UCI Health, Orange
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Smart Cures Clinical Research, Anaheim
  • Cedars-Sinai Medical Center, Beverly Hills
  • United Medical Doctors - Los Alamitos, Los Alamitos
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937099

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of California Davis Comprehensive Cancer Center, Sacramento
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Alliance Research Institute-Site Number: 8400008, Canoga Park
  • Southern California GI & Liver Centers-Site Number: 8400062, Coronado
  • Gastroenterology and Liver Institute - Escondido-Site Number: 8400146, Escondido
  • dan 14 lagi
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • UCSF Benioff Children's Hospital - Oakland /ID# 258327, Oakland
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05995353

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • Gastro Care Institute, Lancaster
  • Infinity Clinical Research, San Diego
Mengambil pesertaFasa 2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • UCSF Medical Center at Mission Bay, San Francisco
Mengambil pesertaFasa 3
Umur 2 hingga 19 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  • Biopharma Informatic, LLC, Los Angeles
  • Om Research LLC, Oxnard
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • University of California San Diego Health (UCSD), La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
  • Hoag Hospital Newport Beach, Newport Beach
Mengambil pesertaFasa 4
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  • Clinnova Research, Anaheim
  • Gastro SB Clinic, Chula Vista
  • United Medical Doctors, Los Alamitos
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07577843

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Cedars Sinai Medical Center, Los Angeles
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05509777

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Hoag Hospital, Irvine
  • UC San Diego Health, La Jolla
  • Cedars-Sinai, Los Angeles
  • dan 1 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05230173

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • Children's Hospital Of Orange County, Orange
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06100289

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

  • UCSF Benioff Children's Hospital - Oakland /ID# 262217, Oakland
  • Lucile Packard Children's Hospital /ID# 262193, Palo Alto
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 24 Jun 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Loma Linda University, Loma Linda
  • Children's Hospital of Orange County, Orange
  • Stanford Children's Health, Palo Alto
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 22 Jun 2026 · NCT06405087

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

  • Cedars-Sinai Medical Center, Beverly Hills
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 5 Jun 2026 · NCT06976853

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Cedars-Sinai, Los Angeles
  • UCSF Benioff Children's Hospitals, San Francisco
Mengambil pesertaFasa 4
Umur 6 hingga 17 · Semua jantina · Dikemas kini 27 Mei 2026 · NCT05781152

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

  • UCSD Medical Center, La Jolla
  • Keck Medicine Of USC - USC Healthcare Center 1, Los Angeles
Mengambil pesertaFasa 3
Umur 18 hingga 65 · Semua jantina · Dikemas kini 27 Mei 2026 · NCT06227910

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • Rady Children's Hospital - San Diego - PIN, San Diego
Mengambil pesertaFasa 3
Umur 2 ke atas · Semua jantina · Dikemas kini 7 Mei 2026 · NCT05442567

Precise Infliximab Exposure and Pharmacodynamic Control

  • Children's Hospital of Los Angeles, Los Angeles
  • Lucile Packard Children's Hospital Stanford, Palo Alto
  • Rady Children's Hospital San Diego, San Diego
Mengambil pesertaFasa 2/3
Umur 6 hingga 22 · Semua jantina · Dikemas kini 5 Mei 2026 · NCT05660746

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • Rady Childrens Hospital San Diego - PIN, San Diego
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 5 Mei 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  • Hoag Hospital, Irvine
  • United Medical Doctors, Murrieta
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400005, Escondido
  • Investigational Site Number: 8400001, Lancaster
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06958536

Effect of Statins on Crohn's Disease

  • Stanford University, Stanford
Mengambil pesertaFasa awal 1
Umur 18 hingga 80 · Semua jantina · Dikemas kini 27 Feb 2026 · NCT06538649

Impact of Prebiotics in Ulcerative Colitis

  • UCLA, Los Angeles
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 27 Feb 2026 · NCT06495658

Stem Cell Transplantation in Crohn's Disease

  • Cedars-Sinai Medical Center, Los Angeles
Mengambil pesertaFasa 1/2
Umur 13 hingga 28 · Semua jantina · Dikemas kini 20 Feb 2026 · NCT04224558

Treatment of Moderate to Severe Refractory Crohn's Disease

  • University of California, Davis, Sacramento
  • University of California, San Francisco, San Francisco
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 10 Dis 2025 · NCT06721962

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

  • University of California, San Diego, La Jolla
Mengambil pesertaKajian pemerhatian
Semua umur · Wanita · Dikemas kini 28 Jan 2025 · NCT02103361

Urine Metabolites in the Diagnosis of Disease

  • Unio Health Partners (Gastroenterology), Encinitas
  • Digestive Health Associates, Santa Monica
  • Westside Gastro Care, Santa Monica
  • dan 1 lagi
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Dis 2024 · NCT06710067

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.